Rete Ridges in Eyelid Margin and Inflammatory Cytokines in Meibomian Gland Dysfunction Associated with Dry Eye Symptom

References

• Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011;52(4):1938–78. doi:10.1167/iovs.10-6997c.
   PubMed Web of Science ®Google Scholar
• Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye (Lond). 2009;23(3):688–93. doi:10.1038/sj.eye.6703101.
   PubMed Web of Science ®Google Scholar
• Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472–78. doi:10.1097/ICO.0b013e318225415a.
   PubMed Web of Science ®Google Scholar
• Eom Y, Lee JS, Kang SY, Kim HM, Song JS. Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls. Am J Ophthalmol. 2013;155:1104–1110 e2. doi:10.1016/j.ajo.2013.01.008.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Sato EA, Ibrahim OM, Dogru M, Tsubota K. The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction. Mol Vis. 2008;14:1263–71.
   PubMed Web of Science ®Google Scholar
• Ibrahim OM, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Goto T, Negishi K, Tsubota K. The efficacy, sensitivity, and specificity of in vivo laser confocal microscopy in the diagnosis of meibomian gland dysfunction. Ophthalmology. 2010;117(4):665–72. doi:10.1016/j.ophtha.2009.12.029.
   PubMed Web of Science ®Google Scholar
• Zhou S, Robertson DM. Wide-field in vivo confocal microscopy of meibomian gland acini and rete ridges in the eyelid margin. Invest Ophthalmol Vis Sci. 2018;59(10):4249–57. doi:10.1167/iovs.18-24497.
   PubMed Web of Science ®Google Scholar
• Villani E, Ceresara G, Beretta S, Magnani F, Viola F, Ratiglia R. In vivo confocal microscopy of meibomian glands in contact lens wearers. Invest Ophthalmol Vis Sci. 2011;52(8):5215–19. doi:10.1167/iovs.11-7427.
   PubMed Web of Science ®Google Scholar
• Ibrahim OM, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Shimazaki J, Fujishima H, Tsubota K. In vivo confocal microscopy evaluation of meiboian gland in atopic-keratoconjunctivitis patients. Ophthalmology. 2012;119:1961–68. doi:10.1016/j.ophtha.2012.04.001.
   PubMed Web of Science ®Google Scholar
• Agnifili L, Fasanella V, Costagliola C, Ciabattoni C, Mastropasqua R, Frezzotti P, Mastropasqua L. In vivo confocal microscopy of meibomian glands in glaucoma. Br J Ophthalmol. 2013;97(3):343–49. doi:10.1136/bjophthalmol-2012-302597.
   PubMed Web of Science ®Google Scholar
• Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, Asbell PA, Pflugfelder SC. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128:94–101. doi:10.1001/archophthalmol.2009.356.
   PubMed Web of Science ®Google Scholar
• Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, Yee R, Yokoi N, Arita R, Dogru M. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006–49. doi:10.1167/iovs.10-6997f.
   PubMed Web of Science ®Google Scholar
• Greiner JV. A single lipiflow ® thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012;37(4):272–78. doi:10.3109/02713683.2011.631721.
   PubMed Web of Science ®Google Scholar
• Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115(5):911–15. doi:10.1016/j.ophtha.2007.06.031.
   PubMed Web of Science ®Google Scholar
• Lee H, Chung B, Kim KS, Seo KY, Choi BJ, Kim T-I. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial. Am J Ophthalmol. 2014;158(6):1172–1183 e1. doi:10.1016/j.ajo.2014.08.015.
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994–2005. doi:10.1167/iovs.10-6997e.
   PubMed Web of Science ®Google Scholar
• Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology. 1993;100(3):347–51. doi:10.1016/S0161-6420(93)31643-X.
   PubMed Web of Science ®Google Scholar
• Craig JP, Singh I, Tomlinson A, Morgan PB, Efron N. The role of tear physiology in ocular surface temperature. Eye (Lond). 2000;14(4):635–41. doi:10.1038/eye.2000.156.
   PubMed Web of Science ®Google Scholar
• Rhee MK, Mah FS. Inflammation in dry eye disease: how do we break the cycle? Ophthalmology. 2017;124(11):S14–S19. doi:10.1016/j.ophtha.2017.08.029.
   PubMed Web of Science ®Google Scholar
• Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147(2):198–205 e1. doi:10.1016/j.ajo.2008.08.032.
   PubMed Web of Science ®Google Scholar
• Acera A, Rocha G, Vecino E, Lema I, Durán JA. Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res. 2008;40(6):315–21. doi:10.1159/000150445.
   PubMed Web of Science ®Google Scholar
• Kang MH, Kim MK, Lee HJ, Lee HI, Wee WR, Lee JH. Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci. 2011;26(7):938–44. doi:10.3346/jkms.2011.26.7.938.
   PubMed Web of Science ®Google Scholar
• Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol. 2010;22(5):347–52. doi:10.1093/intimm/dxq030.
   PubMed Web of Science ®Google Scholar
• Choi W, Noh H, Yeo A, Jang H, Ahn HK, Song YJ, Lee HK. The effect of TNF-α blocker HL036337 and its best concentration to inhibit dry eye inflammation. Korean J Ophthalmol. 2016;30(4):302–08. doi:10.3341/kjo.2016.30.4.302.
   PubMedGoogle Scholar
• Zahir-Jouzdani F, Atyabi F, Mojtabavi N. Interleukin-6 participation in pathology of ocular diseases. Pathophysiology. 2017;24(3):123–31. doi:10.1016/j.pathophys.2017.05.005.
   PubMedGoogle Scholar
• Zhao H, Li Q, Ye M, Yu J. Tear luminex analysis in dry eye patients. Med Sci Monit. 2018;24:7595–602. doi:10.12659/MSM.912010.
   PubMed Web of Science ®Google Scholar
• Choi M, Han SJ, Ji YW, Choi YJ, Jun I, Alotaibi MH, Ko BY, Kim EK, Kim T-I, Nam SM, et al. Meibum expressibility improvement as a therapeutic target of intense pulsed light treatment in meibomian gland dysfunction and its association with tear inflammatory cytokines. Sci Rep. 2019;9(1):7648. doi:10.1038/s41598-019-44000-0.
   PubMed Web of Science ®Google Scholar
• Lehrskov LL, Christensen RH. The role of interleukin-6 in glucose homeostasis and lipid metabolism. Semin Immunopathol. 2019;41(4):491–99. doi:10.1007/s00281-019-00747-2.
   PubMed Web of Science ®Google Scholar
• Saidoune-Malek I, Ait-Lounis A, Laraba-Djebari F. TNF-α antagonist improves oxidative stress and lipid disorders induced by scorpion venom in the intestinal tissue. Acta Trop. 2018;185:307–13. doi:10.1016/j.actatropica.2018.06.013.
   PubMed Web of Science ®Google Scholar
• Nagarajan G, Swami SK, Ghorui SK, Pathak KM, Singh RK, Patil NV. Cloning and sequence analysis of IL-2, IL-4 and IFN-γ from Indian Dromedary camels (Camelus dromedarius). Res Vet Sci. 2012;92(3):420–26. doi:10.1016/j.rvsc.2011.03.028.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol. 2011;89(6):965–72. doi:10.1189/jlb.1110611.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chauhan SK, Shao C, Omoto M, Inomata T, Dana R. IFN-γ–expressing Th17 cells are required for development of severe ocular surface autoimmunity. J Immunol. 2017;199(3):1163–69. doi:10.4049/jimmunol.1602144.
   PubMed Web of Science ®Google Scholar
• Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren’s syndrome. Nat Rev Rheumatol. 2013;9:544–56. doi:10.1038/nrrheum.2013.110.
   PubMed Web of Science ®Google Scholar
• Olsson P, Skogstrand K, Nilsson A, Turesson C, Jacobsson LTH, Theander E, Houen G, Mandl T. Smoking, disease characteristics and serum cytokine levels in patients with primary Sjogren’s syndrome. Rheumatol Int. 2018;38:1503–10. doi:10.1007/s00296-018-4063-8.
   PubMed Web of Science ®Google Scholar